Hip Fractures Clinical Trial
Official title:
Post-market Clinical Follow-up Study to Provide Safety, Performance and Clinical Benefits Data of the Echo FX Stem With the RingLoc Bipolar Acetabular Cup and Femoral Head (Implants and Instrumentation) in Hip Hemiarthroplasty - A Retrospective Enrollment/Prospective Follow-up Consecutive Series Study
The objective of this retrospective enrollment and prospective follow-up study is to confirm safety, performance, and clinical benefits of the Echo FX Stem with the RingLoc Bipolar Acetabular Cup and Femoral Head in hip hemiarthroplasty (implants and instrumentation) at a minimum of 10 years follow-up. All available retrospective data will be collected from each patient and a prospective aspect to the study will be necessary to reach the 10-year time point.
Status | Recruiting |
Enrollment | 86 |
Est. completion date | September 3, 2030 |
Est. primary completion date | September 3, 2030 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patient must be 18 years of age or older and skeletally mature - Patient must be willing and able to sign IRB approved informed consent - Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis - Rheumatoid arthritis - Correction of functional deformity - Treatment of non-union, femoral neck fracture and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques - Revision procedures where other treatment or devices have failed Exclusion Criteria: - Off-label use - Uncooperative patient or patient with neurological disorders who are incapable of following directions - Osteoporosis - Metabolic disorders which may impair bone formation - Osteomalacia - Distant foci of infections which may spread to the implant site - Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram - Vascular insufficiency, muscular atrophy, or neuromuscular disease - Infection - Sepsis - Osteomyelitis - Patient is known to be pregnant or nursing - Patient is a prisoner - Patient is a known alcohol or drug abuser - Patient has a psychiatric illness or cognitive deficit that will not allow for proper informed consent - Patient is unwilling to sign an informed consent |
Country | Name | City | State |
---|---|---|---|
United States | Vicksburg Clinic, LLC | Vicksburg | Mississippi |
Lead Sponsor | Collaborator |
---|---|
Zimmer Biomet |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Device safety assessed through the frequency and incidence of revisions, complications, and Adverse Events. | The primary objective of this study is the assessment of safety by analyzing implant survivorship. This will be established by recording the incidence and frequency of revisions, complications, and Adverse Events. Relation of the events to either implant or instrumentation will be specified. | Out to 10 years. | |
Secondary | Device Performance and Benefits evaluated through the Oxford Hip Score. | The OHS is a patient-completed, 12-question evaluation. Each item is scored from 1 to 5, with 1 representing best outcome/least symptoms and 5 representing worst outcome/most symptoms. | Out to 10 years. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02507609 -
Deep Neuromuscular Block on Cytokines Release and Postoperative Delirium
|
N/A | |
Completed |
NCT03906864 -
Care Pathway for Sub-acute Hip Rehabilitation
|
N/A | |
Recruiting |
NCT04063891 -
Vibration Therapy as an Intervention for Enhancing Trochanteric Hip Fracture Healing in Elderly Patients
|
N/A | |
Completed |
NCT05039879 -
Life Improving Factors After a Hip Fracture
|
||
Not yet recruiting |
NCT03887494 -
Study of the Impact of the Femoral Implant "Y-strut" on Lytic Bone Metastases of the Femoral Neck (WAZA-ARY)
|
N/A | |
Terminated |
NCT03065101 -
Trigen InterTAN vs Sliding Hip Screw RCT
|
N/A | |
Completed |
NCT03545347 -
Physiotherapy, Nutritional Supplement and Anabolic Steroids in Rehabilitation of Patients With Hip Fracture.
|
Phase 2 | |
Completed |
NCT03695081 -
Patient Pathway Pharmacist - Optimal Drug-related Care
|
N/A | |
Recruiting |
NCT05971173 -
Nutritional Optimization and Bone Health Management for Older Adults Undergoing Hip Fracture Surgery
|
Early Phase 1 | |
Active, not recruiting |
NCT04957251 -
Anterior vs Posterior Approach for Hip Hemiarthroplasty
|
N/A | |
Terminated |
NCT04372966 -
Uncemented Versus Cemented Total Hip Arthroplasty for Displaced Intracapsular Hip Fractures
|
N/A | |
Withdrawn |
NCT05030688 -
Fascia Iliaca Compartment Block and PENG Block for Hip Arthroplasty
|
N/A | |
Completed |
NCT04424186 -
'Rehabilitation for Life'
|
N/A | |
Not yet recruiting |
NCT04183075 -
Impact of a Nutritional Supplement on the Recovery of the Nutritional Status of Patients With Spontaneous Hip Fracture
|
N/A | |
Withdrawn |
NCT05518279 -
Early Administration Of Tranexamic Acid And Acute Blood Loss In Patients With Hip Fractures
|
Phase 3 | |
Not yet recruiting |
NCT02892968 -
ED Ultrasonographic Regional Anesthesia to Prevent Incident Delirium in Hip Fracture Patients
|
N/A | |
Not yet recruiting |
NCT02223572 -
Secondary Fracture Prevention in Patients Who Suffered From Osteoporotic Fracture
|
N/A | |
Active, not recruiting |
NCT02247791 -
Uncemented Compared to Cemented Femoral Stems in Total Hip Arthroplasty
|
N/A | |
Completed |
NCT00746876 -
Unipolar or Bipolar Hemiarthroplasty in the Treatment of Displaced Femoral Neck Fractures.
|
N/A | |
Completed |
NCT00058864 -
The HIP Impact Protection Program (HIP PRO)
|
N/A |